T1	intervention 46 54	exercise
T2	No-of-participants 318 327	Forty-six
T3	eligibility 328 381	postmenopausal BCS (≤Stage II, off primary treatment)
T4	duration 403 410	3-month
T5	control 436 449	control group
T7	outcome-Measure 729 768	objective sleep quality (accelerometer)
T6	outcome-Measure 691 727	sleep disturbance (PSQI and PROMIS®)
T8	outcome-Measure 770 785	serum cytokines
T9	outcome-Measure 787 818	accelerometer physical activity
T10	outcome-Measure 820 845	cardiorespiratory fitness
T11	outcome-Measure 847 863	body composition
T12	outcome-Measure 865 872	fatigue
T13	outcome-Measure 878 898	psychosocial factors
T14	outcome 1058 1089	increase in PSQI sleep duration
T15	outcome 1223 1246	PSQI daytime somnolence
T16	outcome 1272 1293	accelerometer latency
T17	outcome 1425 1443	Daytime somnolence
T18	outcome 1536 1547	interleukin
T19	outcome 1608 1615	fatigue
